Video: P&G Shareholders Will Likely Benefit From Peltz Battle
With news that Trian's Nelson Peltz has won more votes in his quest to secure a seat on Procter & Gamble's PG board, regardless of the final outcome, shareholders should benefit.
With news that Trian's Nelson Peltz has won more votes in his quest to secure a seat on Procter & Gamble's (PG) board, regardless of the final outcome, shareholders should benefit.
That's the assessment from Matthew Cheslock, an equity trader with Virtu Financial.
Procter & Gamble shares are up 6% since the start of the year, compared to the S&P 500's 15% rise.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.
Email
Email sent
Thank you, your email to has been sent successfully.
